MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.
Radiation Physics, Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
Int J Radiat Biol. 2022;98(3):439-451. doi: 10.1080/09553002.2021.1988178. Epub 2021 Nov 2.
Hypoxia (low oxygen) is a common feature of solid tumors that has been intensely studied for more than six decades. Here we review the importance of hypoxia to radiotherapy with a particular focus on the contribution of hypoxia to immune responses, metastatic potential and FLASH radiotherapy, active areas of research by leading women in the field.
Although hypoxia-driven metastasis and immunosuppression can negatively impact clinical outcome, understanding these processes can also provide tumor-specific vulnerabilities that may be therapeutically exploited. The different oxygen tensions present in tumors and normal tissues may underpin the beneficial FLASH sparing effect seen in normal tissue and represents a perfect example of advances in the field that can leverage tumor hypoxia to improve future radiotherapy treatments.
缺氧(低氧)是实体瘤的一个常见特征,已经被深入研究了六十多年。在这里,我们回顾了缺氧对放射治疗的重要性,特别关注了缺氧对免疫反应、转移潜能和 FLASH 放射治疗的贡献,这些都是该领域领先女性的研究重点。
虽然缺氧驱动的转移和免疫抑制会对临床结果产生负面影响,但了解这些过程也可以为肿瘤提供特异性弱点,这些弱点可能可以被治疗性地利用。肿瘤和正常组织中存在的不同氧张力可能是正常组织中看到的有益的 FLASH 保护效应的基础,这是该领域进展的一个完美例子,可以利用肿瘤缺氧来改善未来的放射治疗。